https://www.selleckchem.com/pr....oducts/4-hydroxynone
5%, p0.001). The number of CD34+ cells collected was significantly higher in patients within three courses of RAD than in patients with four or five to six courses (14.18±13.57 vs. 2.07±2.42 vs. 1.51±1.81×10 /kg, p=0.028). The median progression-free survival and overall survival of the two groups were not reached by the end of follow-up. Compared to PAD, RAD induction had comparable efficacy and a significantly better safety profile, improved quality of life for patients, and reduced occupational stress for doctors. Howeve
Like
Comment
Share
